Treatment for Clostridium-difficile Infection With IMM529, page-10

Correct. I think the big question is whether the FDA will offer an approval pathway to a NASH drug that targets only inflammation and not fat. Yet to be seen. I think that's why the U.S. market writes us off. No effect on steatosis. Then again, just eating green vegetables decreases steatosis, so who the hell knows what drugs like Intercept Pharma's or Viking Pharma's are worth either: https://www.google.com/url?sa=t&source=web&rct=j&url=https://medicalxpress.com/news/2018-12-green-leafy-vegetables-liver-steatosis.amp&ved=2ahUKEwjPvIjwtKrfAhUS0FkKHddZBHEQyM8BMA96BAgBEAM&usg=AOvVaw101VZR4kcQFsyqNdDEtUk-&cf=1